The place of imaging methods in the treatment of Parkinson's disease;Stellenwert bildgebender verfahren für die therapie der patienten mit Parkinsonsyndrom

Deutsche Medizinische Wochenschrift

Volumn 133, Issue 18 SUPPL. 1, 2008, Pages

  Schwarz, Johannes ^a   Gratz, S ^b   Hahn, U ^b   Forstl H ^c   Jarnig, M ^d  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Stuttgart Bad Cannstatt ^*

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d GE HEALTHCARE   (Germany)

Author keywords

DaT SCAN; Dopaminergic neurons; Morbus Parkinson; SPEC analysis

Indexed keywords

DOPAMINE TRANSPORTER; IOFLUPANE; RADIOPHARMACEUTICAL AGENT; DOPAMINE RECEPTOR STIMULATING AGENT;

DOPAMINERGIC NERVE CELL; HUMAN; IMAGE ANALYSIS; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; COST BENEFIT ANALYSIS; ECONOMICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SENSITIVITY AND SPECIFICITY; SUBSTANTIA NIGRA;

COST-BENEFIT ANALYSIS; DOPAMINE AGENTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; SUBSTANTIA NIGRA; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 44449149729     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1075679     Document Type: Review

References (17)

1. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184
2. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988; 51: 745-752
3. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002; 125: 861-870
4. Parkinson Study Group. A randomized controlled trial comparing pramipexole with levodopa in early Parkinson's disease: design and methods of the CALM-PD Study. Clin Neuropharmacol 2000; 23: 34-44
5. Fahn S, Oakes D, Shoulson I et al. Levodopa and the progression of Parkinson's disease. N Engl J Med 2004; 351: 2498-2508
6. Oertel WH, Wolters E, Sampaio C et al. Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study. Mov Disord 2006; 21: 343-353
7. Whone AL, Watts RL, Stoessl AJ et al. Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study. Ann Neurol 2003; 54: 93-101
8. Catafau AM, Tolosa E. Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes. Mov Disord 2004; 19: 1175-1182
9. Hesse S, Oehlwein C, Barthel H et al. Possible impact of dopamine SPECT on decision-making for drug treatment in Parkinsonian syndrome. J Neural Transm 2006; 113: 1177-1190
10. Benamer HT, Patterson J, Wyper DJ et al. Correlation of Parkinson's disease severity and duration with 123I-FP- CIT SPECT striatal uptake. Mov Disord 2000; 15: 692-698
11. Rajput AH, Moghal S, Rajput A. Parkinson's disease and essential tremor. Neurology 1994; 44: 778-
12. Benamer TS, Patterson J, Grosset DG et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord 2000; 15: 503-510
13. Tolosa E, Coelho M, Gallardo M. DAT imaging in drug-induced and psychogenic parkinsonism. Mov Disord 2003; 18, Suppl 7: 28-33
14. Gerschlager W, Bencsits G, Pirker W et al. [123I]beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease. Mov Disord 2002; 17: 518-523
15. Scherfler C, Seppi K, Donnemiller E et al. Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease. Brain 2005; 128: 1605-1612
16. Schwarz J, Tatsch K, Arnold G et al. 123I-iodobenzamide-SPECT in 83 patients with de novo parkinsonism. Neurology 1993; 43: S17-20
17. Dodel RC, Hoffken H, Moller JC et al. Dopamine transporter imaging and SPECT in diagnostic work-up of Parkinson's disease: a decision-analytic approach. Mov Disord 2003; 18, Suppl 7: 52-62